Stock Details
FMS is Fresenius Medical Care AG & Co. KGaA's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 17.42$. Average daily volumn in 3 months 961.78k. Market cap 8.88B

Stock symbol : FMS. Exchange : NYSE. Currency : USD
Lastest price : 14.89$. Total volume : 557.50k. Market state REGULAR
Click reload if you want to check the lastest price on market!!!

Fresenius Medical Care AG & Co. KGaA (FMS)
Last Price

Previous Close14.22
Day Range14.60-14.91
Bid14.83 x 900
Ask14.84 x 800
Average Volume961.78k
Market Cap8.88B
52 Week Range13.69-36.08
Trailing P/E11.19
Foward P/E6.23
Dividend (Yield %)5.05%
Ex-Dividend Date2022-05-13

Financial Details

According to Fresenius Medical Care AG & Co. KGaA's financial reports the company's revenue in 2021 were 17.62B an decrease(0%) over the years 2020 revenue that were of 17.86B. In 2021 the company's total earnings were 969.31M while total earnings in 2020 were 1.16B(-3.1%).

Loading ...


Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the... United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of February 23, 2022, it operated 4,171 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Market Cap:
Total Assets:
Total Cash:

News about "Fresenius Medical Care AG & Co. KGaA"


Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Earns Buy Rating from Analysts at

Source from : Defense World - 2 days ago

Stock analysts at began coverage on shares of Fresenius Medical Care AG & Co. KGaA (NYSE:FMS โ€“ Get Rating) in a report issued on Sunday. The firm set a โ€œbuyโ€ rating on the stock. FMS has ...See details»

Fresenius Medical Care AG & Co. KGaA (FMS)

Source from : Yahoo Finance - 1 days ago

*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...See details»


Bank of America Corp DE Purchases 236,459 Shares of Fresenius Medical Care AG & Co. KGaA (NYSE:FMS)

Source from : Defense World - 3 days ago

Bank of America Corp DE boosted its position in Fresenius Medical Care AG & Co. KGaA (NYSE:FMS โ€“ Get Rating) by 27.9% in the first quarter, according to its most recent filing with the SEC. The ...See details»

Fresenius SE & Co KGaA

Source from : Reuters - 4 days ago

Fresenius SE & Co KGaA is a Germany-based healthcare group. It operates through four business segments. Fresenius Medical Care runs a global network of dialysis clinics, providing treatment for ...See details»

Fresenius Medical Care (NYSE: FMS)

Source from : The Motley Fool - 20 days ago

The company makes and sells products for all forms of kidney dialysis to health-care providers throughout the world, along with providing kidney dialysis treatment and other medical ancillary ...See details»

Fresenius Medical Care partners with National Kidney Foundation Malaysia in kidney health initiative

Source from : Stockhouse - 27 days ago

These and other risks and uncertainties are detailed in Fresenius Medical Care AG & Co. KGaA's reports filed with the U.S. Securities and Exchange Commission. Fresenius Medical Care AG & Co. KGaA does ...See details»

Continuous Renal Replacement Therapy Market to surpass USD 1.68 Bn by 2027, Says FMI

Source from : PharmiWeb - 12 hours ago

The globalย continuous renal replacement therapy marketย was valued at US$ US$ 743 Mn in terms of value in 2016, according to a latest research by Future Market Insights (FMI). The report on continuous ...See details»


USD 155.43 Bn Growth in Medical Devices Market Size, Majority of Market Growth to Originate from North America - Technavio

Source from : Yahoo - 1 days ago

The medical devices market is fragmented, and the vendors are deploying organic and inorganic growth strategies to compete in the market. The market is highly competitive due to the presence of many ...See details»

Fresenius Recalls Dialysis Concentrate, May Be Contaminated

Source from : MD&M East - 13 days ago

Fresenius Medical Care is one of four arms of Fresenius SE & Co. KgaA, which makes its headquarters in Bad Homburg, Germany. The other three business units are Fresenius Kabi, which develops, produces ...See details»

Fresenius Medical Care Wins Major Award to Support U.S. Veterans with Industry-Leading Dialysis Care

Source from : Yahoo - 1 month ago

Aug. 30, 2022 /PRNewswire/ -- Fresenius Medical North America's (FMCNA) Renal Therapies Group, the leading provider of kidney care products, will be a company of choice to help treat the more than ...See details»

The Global Biosimilars Market size is expected to reach $59 billion by 2028, rising at a market growth of 24.4% CAGR during the forecast period

Source from : - 1 days ago announces the release of the report "Global Biosimilars Market Size, Share & Industry Trends Analysis Report By Application, By Type, By Regional ...See details»

Fresenius Kidney Care Celebrates Nephrology Nurses Week with The CARE Award

Source from : Stockhouse - 22 days ago

About Fresenius Kidney Care Fresenius Kidney Care, a division of Fresenius Medical Care North America (FMCNA), provides kidney disease education, dialysis treatment, and support services to more than ...See details»

Smart Infusion Pump Market with Tremendous growth by 2029 Fresenius Kabi AG, Q Core Medical Ltd., Becton

Source from : Digital Journal - 23 days ago

Some of the Top companies Influencing this Market include:Fresenius Kabi AG, Q Core Medical Ltd., Becton, Dickinson and Company, Micrel Medical Devices SA, Baxter International, Inc., Smiths ...See details»

New standards set for Acute Kidney Injury Treatment Market grow at 8.62% CAGR| 112 Report Pages

Source from : MarketWatch - 6 days ago

The global Acute Kidney Injury Treatment market size is expected to expand at a CAGR of 8.62% during the forecast ...See details»